Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. [electronic resource]
- Mayo Clinic proceedings Jul 1993
- 670-9 p. digital
Publication Type: Journal Article; Review
0025-6196
10.1016/s0025-6196(12)60603-x doi
5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists--adverse effects Aged Aged, 80 and over Androstenes--adverse effects Azasteroids--adverse effects Finasteride Humans Male Prostatic Hyperplasia--drug therapy